Mark Auerbach - Dec 23, 2021 Form 3 Insider Report for PARDES BIOSCIENCES, INC. (PRDS)

Role: Director
Signature: /s/ Elizabeth Lacy, attorney-in-fact
Stock symbol: PRDS
Transactions as of: Dec 23, 2021
Transactions value $: $0
Form type: 3
Date filed: 12/27/2021, 04:27 PM
Next filing: Jun 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PRDS	Common Stock						70.4K	Dec 23, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24 - Power of Attorney Effective immediately following the effective time of the merger pursuant to that certain Agreement and Plan of Merger dated as of June 29, 2021, as amended, by and among Pardes Biosciences Sub, Inc. (f/k/a Pardes Biosciences, Inc.), Issuer (f/k/a FS Development Corp. II), and certain other parties thereto, the reporting person became a director of the Issuer.